Intervention

Influenza vaccine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6
Recruiting0
Common conditions9
Lead sponsors shown6
Advertisement

Clinical trials

6 shown
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular PrognosisNCT02831608 · 2016-10-01
COMPLETED
VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)NCT03955991 · 2016-07-21
COMPLETED
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)NCT02268500 · 2014-09-01
COMPLETED
Duration of Immune Response to Influenza Vaccination in Patients With RANCT02311855 · 2014-08-01
COMPLETED
Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on TeriflunomideNCT01403376 · 2011-09-01
COMPLETED
The Effect of Rituximab on the Humoral Response to Influenza VaccineNCT00466037 · 2005-09-01
TERMINATED

Trial status mix

COMPLETED5
TERMINATED1

Phase mix

PHASE44
NA1
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.